Areas of Focus:

Biological & MechanisticClinical TrialsCollaboration & InnovationCross-institutional CollaborationData-Driven & QuantitativeExperimental Platforms & ModelsHuman CohortsMicrobiome–Immune InteractionsMulti-omics IntegrationTherapeutic DevelopmentTranslational & ClinicalRheumatoid ArthritisSystemic Diseases
  • Assistant Professor, Department of Medicine, NYU Grossman School of Medicine / NYU Langone Health

Dr. Rebecca B. Blank is an Assistant Professor in the Department of Medicine at NYU Grossman School of Medicine specializing in rheumatoid arthritis (RA). She earned her PhD in Immunology at the University of California, San Francisco, and her MD from the Icahn School of Medicine at Mount Sinai. Her postdoctoral research at the National Institutes of Health examined the role of regulatory T cells in modulating gut inflammation. She completed her residency in Internal Medicine at NewYork-Presbyterian/Weill Cornell Medical Center and her Rheumatology fellowship at NYU Langone Health.

Dr. Blank’s research centers on the role of the gut microbiome in the pathogenesis and treatment of inflammatory arthritis, particularly RA. She currently leads two proof-of-concept clinical trials investigating how the gut microbiome and its metabolic byproducts — including short-chain fatty acids (SCFAs) — may modulate immune responses and promote immune regulation in RA patients. She also pursues the identification of predictive biomarkers of treatment efficacy in RA, with the goal of enabling more personalized therapeutic approaches.